Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamic Medical TechnologiesROCO:4138 +0.96%82 Piotroski F-Score is 5 as of Aug. 30, 2026, which is at its 10-year median of 5.00. GuruFocus rates ROCO:4138 with a GF Score™ of 82/100 and a GF Value™ of NT$72.57 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Dynamic Medical Technologies ranks better than 63.05% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Dynamic Medical Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Dynamic Medical Technologies's Piotroski F-Score or its related term are showing as below:
ROCO:4138'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 5 Max: 8
Current: 5
During the past 13 years, the highest Piotroski F-Score of Dynamic Medical Technologies was 8. The lowest was 4. And the median was 5.
Dynamic Medical Technologies (ROCO:4138) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Dynamic Medical Technologies Piotroski F-Score Related Terms
Dynamic Medical Technologies Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies Piotroski F-Score Chart
ROCO:4138 vs ABT, SYK, MDT: Piotroski F-Score Comparison
For the Medical Devices subindustry, Dynamic Medical Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamic Medical Technologies Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Dynamic Medical Technologies's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 36.344 + 36.616 + 33.413 + 39.695 = NT$146 Mil. Cash Flow from Operations was 38.148 + 246.378 + -29.718 + 69.738 = NT$325 Mil. Revenue was 338.013 + 370.293 + 342.776 + 344.397 = NT$1,395 Mil. Gross Profit was 151.506 + 165.302 + 138.826 + 150.32 = NT$606 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(2859.161 + 2978.317 + 3126.647 + 3151.012 + 2961.334) / 5 = NT$3015.2942 Mil. Total Assets at the begining of this year (Jun25) was NT$2,859 Mil. Long-Term Debt & Capital Lease Obligation was NT$290 Mil. Total Current Assets was NT$1,847 Mil. Total Current Liabilities was NT$851 Mil.
Net Income was 47.737 + 59.789 + 41.537 + 37.562 = NT$187 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Dynamic Medical Technologies's current Net Income (TTM) was 146.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Dynamic Medical Technologies's current Cash Flow from Operations (TTM) was 325.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Dynamic Medical Technologies's return on assets of this year was 0.05108771. Dynamic Medical Technologies's return on assets of last year was 0.06487615.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Dynamic Medical Technologies's gearing of this year was 0.09603938. Dynamic Medical Technologies's gearing of last year was 0.11129865.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Dynamic Medical Technologies's current ratio of this year was 2.1703937. Dynamic Medical Technologies's current ratio of last year was 2.1426454.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Dynamic Medical Technologies's number of shares in issue this year was 40.096. Dynamic Medical Technologies's number of shares in issue last year was 39.96.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Dynamic Medical Technologies's gross margin of this year was 0.43422653. Dynamic Medical Technologies's gross margin of last year was 0.44056877.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Dynamic Medical Technologies's asset turnover of this year was 0.4880729. Dynamic Medical Technologies's asset turnover of last year was 0.5038957.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
1
+
0
+
0
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Dynamic Medical Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.
Dynamic Medical Technologies (ROCO:4138) has a Piotroski F-Score of 5 as of Aug. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dynamic Medical Technologies and its competitors. This is near median its historical median of 5.00. Over the past decade, Dynamic Medical Technologies' Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Dynamic Medical Technologies ranks #300 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 36.9%.
Is Dynamic Medical Technologies' Piotroski F-Score too high?
Dynamic Medical Technologies' current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Dynamic Medical Technologies' value of 5 is 0% at this industry median. Based on the distribution chart, Dynamic Medical Technologies ranks #300 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dynamic Medical Technologies has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Dynamic Medical Technologies ranks #300 out of 812 companies for Piotroski F-Score. This puts Dynamic Medical Technologies in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Dynamic Medical Technologies' value of 5 is 0% at this benchmark. Historically, Dynamic Medical Technologies' own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Dynamic Medical Technologies has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamic Medical Technologies's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dynamic Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamic Medical Technologies's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$72.57, compared to a current price of NT$52.80 — trading 27.2% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Medical Devices & Instruments industry median of 5.00. Dynamic Medical Technologies' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current Piotroski F-Score is 5 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?
Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued.
The current stock price of NT$52.80 is trading 27.2% below its estimated GF Value™ of NT$72.57.
GuruFocus considers Dynamic Medical Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:4138:
Piotroski F-Score: 5 (near median its 10-year median of 5.00)
GF Value™: NT$72.57 vs. price of NT$52.80 (27.2% below fair value)
Industry Position: 0% at the Medical Devices & Instruments median (#300 of 812)
No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
82GF Score
Get the complete analysis for ROCO:4138
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4138 has been successfully added to your 
